MA41125A - Dérivés de 6.7-cyclomorphinane et leur utilisation - Google Patents

Dérivés de 6.7-cyclomorphinane et leur utilisation

Info

Publication number
MA41125A
MA41125A MA041125A MA41125A MA41125A MA 41125 A MA41125 A MA 41125A MA 041125 A MA041125 A MA 041125A MA 41125 A MA41125 A MA 41125A MA 41125 A MA41125 A MA 41125A
Authority
MA
Morocco
Prior art keywords
cyclomorphinane
derivatives
cyclomorphinane derivatives
Prior art date
Application number
MA041125A
Other languages
English (en)
Inventor
Andrew Kassick
Dawit Tadesse
Laykea Tafesse
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of MA41125A publication Critical patent/MA41125A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA041125A 2014-12-05 2015-12-02 Dérivés de 6.7-cyclomorphinane et leur utilisation MA41125A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462088300P 2014-12-05 2014-12-05

Publications (1)

Publication Number Publication Date
MA41125A true MA41125A (fr) 2017-10-10

Family

ID=56092474

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041125A MA41125A (fr) 2014-12-05 2015-12-02 Dérivés de 6.7-cyclomorphinane et leur utilisation

Country Status (4)

Country Link
US (1) US10435406B2 (fr)
EP (1) EP3227293A4 (fr)
MA (1) MA41125A (fr)
WO (1) WO2016090158A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3389656A4 (fr) * 2015-12-17 2019-06-19 Trevena, Inc. Combinaisons de ligands de récepteurs opioïdes et d'inhibiteurs du cytochrome p450
WO2020205735A1 (fr) * 2019-03-29 2020-10-08 Humanwell Pharmaceutical US Nouveaux morphinanes utiles pour le traitement de troubles médicaux

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US6277875B1 (en) 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
CN1507448A (zh) 2001-03-02 2004-06-23 ���ŷ� N-丁-3-烯基降丁丙诺啡及其作为止痛药的用途
US6740641B2 (en) 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
MXPA05003104A (es) 2002-09-25 2005-05-27 Euro Celtique Sa Hidromorfonas n-sustituidas y uso de las mismas.
EP1554290B1 (fr) 2002-10-25 2009-09-30 Euro-Celtique S.A. Analogues et promedicaments de buprenorphine
US7202259B2 (en) 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US6958398B1 (en) 2002-12-30 2005-10-25 Euro-Celtique S.A. Methods for making thebaine or its acid salts
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
ES2389456T3 (es) 2006-11-01 2012-10-26 Purdue Pharma Lp Compuestos de fenilpropionamida y uso de los mismos
CN101210016B (zh) * 2006-12-29 2011-07-20 中国科学院上海药物研究所 一类杂环并吗啡喃类化合物、制备方法及用途
MX2010006027A (es) 2007-11-30 2010-12-21 Purdue Pharma Lp Compuestos benzomorfano.
CN101481376A (zh) * 2008-01-10 2009-07-15 中国科学院上海药物研究所 一类杂环并14-羟基-吗啡喃类化合物、制备方法及用途
US8530494B2 (en) 2008-07-30 2013-09-10 Purdue Pharma Lp Buprenophine analogs
ME02367B (fr) 2010-09-21 2016-06-20 Purdue Pharma Lp Analogues de buprénorphine
JP5946921B2 (ja) 2011-12-08 2016-07-06 パーデュー、ファーマ、リミテッド、パートナーシップ 四級化ブプレノルフィン類似体
WO2013167963A1 (fr) 2012-05-11 2013-11-14 Purdue Pharma L.P. Composés de type benzomorphane utilisés en tant que modulateurs des récepteurs aux opiacés
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides
US10138207B2 (en) 2012-11-09 2018-11-27 Purdue Pharma, L.P. Benzomorphan analogs and the use thereof
TW201434842A (zh) 2012-12-07 2014-09-16 Purdue Pharma Lp 丁基原啡因（ｂｕｐｒｅｎｏｒｐｈｉｎｅ）類似物類
ES2631197T3 (es) 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes
US8937084B2 (en) 2012-12-14 2015-01-20 Purdue Pharma L.P. Nitrogen containing morphinan derivatives and the use thereof
EP2931726B1 (fr) 2012-12-14 2017-01-25 Purdue Pharma LP Morphinanes spirocycliques et leur utilisation
CA2896202A1 (fr) 2012-12-28 2014-07-03 Purdue Pharma L.P. Morphinanes substitues et utilisation de ceux-ci
EP2941430B1 (fr) 2012-12-28 2017-04-26 Purdue Pharma LP Analogues de 7,8-cyclicmorphinane
EP2951160B1 (fr) 2013-01-31 2019-04-24 Purdue Pharma LP Analogues de benzomorphane et leur utilisation
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
EP3087078B1 (fr) 2013-12-26 2019-05-15 Purdue Pharma LP Analogues 7-bêta-alkyle d'orvinols
US9862726B2 (en) 2013-12-26 2018-01-09 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
EP3087057A4 (fr) 2013-12-26 2017-06-28 Purdue Pharma LP Morphinanes à cycle contracté et leur utilisation
WO2015097546A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Composés à base de propellane et utilisation de ces derniers en qualité de modulateurs de récepteurs d'opioïdes
US20160333020A1 (en) 2013-12-26 2016-11-17 Purdue Pharma L.P. 7-beta analogs of orvinols
EP3086790A4 (fr) 2013-12-27 2017-07-19 Purdue Pharma LP Analogues de la morphinane 6-substitués et 7-substitués, et leurs utilisations
WO2015102682A1 (fr) 2013-12-30 2015-07-09 Purdue Pharma L.P. Analogues de morphinane pyridone-sulfones utilisés comme ligands de récepteurs opioïdes
US10738026B2 (en) 2014-02-12 2020-08-11 Purdue Pharma L.P. Isoquinoline derivatives and use thereof
CA2948144A1 (fr) 2014-05-06 2015-11-12 Purdue Pharma L.P. Analogues du benzomorphane et leur utilisation
CA2950567A1 (fr) 2014-05-27 2015-12-03 Purdue Pharma L.P. Morphinanes spirocycliques et utilisation associee
CA2951697A1 (fr) 2014-06-13 2015-12-17 Purdue Pharma L.P. Derives d'azamophinan et leur utilisation
EP3154971A4 (fr) 2014-06-13 2017-11-01 Purdue Pharma L.P. Dérivés hétérocycliques de morphinan et leur utilisation
WO2016044546A1 (fr) 2014-09-17 2016-03-24 Purdue Pharma L.P. Analogues de benzomorphane et leur utilisation

Also Published As

Publication number Publication date
EP3227293A4 (fr) 2018-09-12
US10435406B2 (en) 2019-10-08
US20180265510A1 (en) 2018-09-20
WO2016090158A1 (fr) 2016-06-09
EP3227293A1 (fr) 2017-10-11

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
MA47440A (fr) Sulfonylurées, composés apparentés, et leur utilisation
DK3466976T3 (da) Anti-her2-antistof-lægemiddelkonjugat
BR112016023628A2 (pt) composições farmacêuticas.
HRP20260361T1 (hr) Supstituirani 4-fenilpiperidini, njihova priprava i uporaba
LT3189056T (lt) Citotoksiniai benzodiazepinai
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
KR20180084876A (ko) 내플라즈마성 부재
BR112017012358A2 (pt) artigo absorvente.
FR3023988B3 (fr) .
DK3126486T3 (da) Immunassay, der benytter indfangningskonjugat
FR3023171B1 (fr) Autoinjecteur.
DE112014006148A5 (de) Schubladenausziehführung
DK3166473T3 (da) Oftalmoskoper
ES1150114Y (es) Abarcón.
MA40524A (fr) Dérivés d'adrénomédulline stabilisés et leur utilisation
FR3023170B1 (fr) Autoinjecteur.
PL4059379T3 (pl) Szuflada
JP1627518S (ja) 引き出し
EP3527133A4 (fr) Audiomètre
PL2946937T3 (pl) Urządzenie drukujące i odpowiedni sposób
DE112015002884A5 (de) Schublade
FI10441U1 (fi) Suodatinjärjestely
EP3371192A4 (fr) Dérivés de podophyllotoxine et leur utilisation